Page last updated: 2024-08-17

triamcinolone acetonide and 4-(3-butoxy-4-methoxybenzyl)-2-imidazolidinone

triamcinolone acetonide has been researched along with 4-(3-butoxy-4-methoxybenzyl)-2-imidazolidinone in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Burns, TL; Rusin, LJ; Stawiski, MA; Voorhees, JJ; Weinstein, GD1
Black, AC; Sandquist, D; Williams, LR; Williams, TH1

Trials

1 trial(s) available for triamcinolone acetonide and 4-(3-butoxy-4-methoxybenzyl)-2-imidazolidinone

ArticleYear
Ro 20-1724: an agent that significantly improves psoriatic lesions in double-blind clinical trials.
    The Journal of investigative dermatology, 1979, Volume: 73, Issue:4

    Topics: 4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone; Adolescent; Adult; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Imidazoles; Male; Placebos; Psoriasis; Triamcinolone Acetonide

1979

Other Studies

1 other study(ies) available for triamcinolone acetonide and 4-(3-butoxy-4-methoxybenzyl)-2-imidazolidinone

ArticleYear
Glucocorticoids increase tyrosine hydroxylase activity in cultured murine neuroblastoma.
    Journal of neurochemistry, 1981, Volume: 36, Issue:6

    Topics: 4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone; Androstenedione; Animals; Cells, Cultured; Cortodoxone; Cyclic AMP; Dexamethasone; Estradiol; Ethanol; Glucocorticoids; Mice; Neuroblastoma; Testosterone; Triamcinolone Acetonide; Tyrosine 3-Monooxygenase

1981